Heart Failure
Black patients may be at elevated cardiotoxicity, HF risk after chemotherapy
Results of a large meta-analysis indicated that Black race was associated with greater odds of cardiotoxicity and HF diagnosis after chemotherapy compared with white and non-Black race, a speaker reported.
‘Dips’ in eGFR after sacubitril/valsartan transition should not stall HF therapy
Declines in renal function observed during transition from a renin-angiotensin system inhibitor to sacubitril/valsartan for HF are variable but usually small and partially recoverable for most patients, researchers reported.
Social deprivation index may predict outcomes after PCI
High social deprivation index as a marker of lower socioeconomic resources is associated with increased risk for recurrent hospitalization for congestive heart failure and death after PCI, researchers reported.
SGLT2 inhibitor therapy reduces sudden cardiac death risk in heart failure
SGLT2 inhibitor therapy in patients with heart failure is associated with a significantly lower incidence of sudden cardiac death vs. placebo, with the benefit persisting independent of other guideline-directed medical therapies.
Group decision dynamics may impact who receives advanced HF therapies
Better group dynamics among a team of HF specialists are significantly associated with greater likelihood of allocating advanced HF therapies to women, irrespective of patient race and ethnic group, researchers reported.
Virtual care team model improves prescribing of heart failure drugs: IMPLEMENT-HF
NEW ORLEANS — A virtual care team-guided strategy improved guideline-directed medical therapy for inpatients with HF with reduced ejection fraction across multiple hospitals in an integrated health care system, researchers reported.
Heart failure with preserved ejection fraction prevalent among patients with CKD
Among patients with chronic kidney disease, heart failure with preserved ejection fraction was highly prevalent, according to data published in Kidney Medicine.
Lifelong bachelorhood tied to mortality in men with heart failure
NEW ORLEANS — Lifelong bachelor status was associated with elevated risk for mortality in men, but not women, with heart failure, researchers reported at the American College of Cardiology Scientific Session.
Race, ethnicity may predict in-hospital outcomes after AF ablation in patients with HF
NEW ORLEANS — In patients with HF, race and ethnicity predicted the likelihood of in-hospital mortality and other outcomes after ablation for atrial fibrillation, researchers reported.
Tailored EHR alert increases prescribing for recommended heart failure drug
NEW ORLEANS — An automated, patient-specific, electronic health record-embedded tool was associated with increased prescriptions of mineralocorticoid receptor antagonists for patients with HF, the BETTER CARE-HF study showed.